Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

Hepatology

Volumn 46, Issue 6, 2007, Pages 1769-1778

  Wu, Jun ^a   Lu, Mengji ^a   Meng, Zhongji ^a,b   Trippler, Martin ^a   Broering, Ruth ^a   Szczeponek, Agnes ^a   Krux, Frank ^a   Dittmer, Ulf ^a   Roggendorf, Michael ^a   Gerken, Guido ^a   Schlaak, Joerg F ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

(2,3 BISPALMITOYLOXYPROPYL)CYSTEINYLGLYCYLASPARTYLPROLYLHISTIDYLPROLYLLYSYLSERYL PHENYLALANINE; ANTIVIRUS AGENT; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; FLAGELLIN; GARDIQUIMOD; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; PALMITOYL 3 CYSTEINE SERINELYSINE 4; POLYINOSINIC POLYCYTIDYLIC ACID; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 1 AGONIST; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR 9 AGONIST; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; HEPATITIS B VIRUS; INNATE IMMUNITY; KUPFFER CELL; LISTERIA MONOCYTOGENES; LIVER; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOUTHERN BLOTTING; VIRUS REPLICATION;

ANIMALS; DENDRITIC CELLS; ENDOTHELIAL CELLS; HEPATITIS B VIRUS; HEPATOCYTES; IMMUNITY, NATURAL; INTERFERON-BETA; KUPFFER CELLS; LIVER; MICE; MICE, INBRED C57BL; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; VIRUS REPLICATION;

EID: 37749050365     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21897     Document Type: Article

References (42)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-1133.
2. Lok AS, McMahon BJ, Practice Guidelines Committee. AASLD Practice Guidelines: Chronic hepatitis B: update of therapeutic guidelines. HEPATOLOGY 2004;39:857-861.
3. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005;79:7269-7272.
4. Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, Caspar P, et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol 2003;171:4758-4764.
5. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003;424:743-748.
6. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 2004;101:5598-5603.
7. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
8. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006;117:979-987.
9. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology 2006;130:1886-1900.
10. Dunne A, O'Neill LA. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett 2005;579:3330-3335.
11. Takeuchi O, Akira S. MyD88 as a bottle neck in Toll/IL-1 signaling. Curr Top Microbiol Immunol 2002;270:155-167.
12. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 2003;198:1043-1055.
13. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev 2000;174:21-34.
14. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 2002;169:5188-5195.
15. Murray JM, Wieland SF, Purcell RH, Chisari FV. Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci U S A 2005;102:17780-17785.
16. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998;9:143-150.
17. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 1995;22:226-229.
18. Maier H, Isogawa M, Freeman GJ, Chisari FV. PD-1:PD-L1 Interactions Contribute to the Functional Suppression of Virus-Specific CD8+ T Lymphocytes in the Liver. J Immunol 2007;178:2714-2720.
19. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-1702.
20. Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in transgenic mice. J Virol 1995;69:6158-6169.
21. Pasquetto V, Wieland SF, Uprichard SL, Tripodi M, Chisari FV. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol 2002;76:5646-5653.
22. Guan SH, Lu M, Grunewald P, Roggendorf M, Gerken G, Schlaak JF. Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J Gastroenterol 2007;13:228-235.
23. Wieland SF, Guidotti LG, Chisari FV. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B vitus transgenic mice. J Virol 2000;74:4165-4173.
24. McClary H, Koch R, Chisari FV, Guidotti LG. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 2000;74:2255-2264.
25. Racanelli V, Rehermann B. The liver as an immunological organ. HEPATOLOGY 2006;43:S54-S62.
26. Breiner KM, Schaller H, Knolle PA. Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver targeting of hepatotropic micro-organisms. HEPATOLOGY 2001;34:803-808.
27. Pasquetto V, Guidotti LG, Kakimi K, Tsuji M, Chisari FV. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J Exp Med 2000;192:529-536.
28. Guidotti LG, Borrow P, Brown A, McClary H, Koch R, Chisari FV. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med 1999;189:1555-1564.
29. Klocker U, Schultz U, Schaller H, Protzer U. Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication. J Virol 2000;74:5525-5533.
30. Tang TJ, Kwekkeboom J, Laman JD, Niesters HG, Zondervan PE, de Man RA, et al. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection. J Viral Hepat 2003;10:159-167.
31. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 2004;101:6669-6674.
32. Cheng J, Imanishi H, Morisaki H, Liu W, Nakamura H, Morisaki T, et al. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1. J Hepatol 2005;43:465-471.
33. Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. HEPATOLOGY 2007;45:102-110.
34. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004;430:257-263.
35. Lee J, Wu CC, Lee KJ, Chuang TH, Katakura K, Liu YT, et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A 2006;103:1828-1833.
36. Roohvand F, Aghasadeghi MR, Sadat SM, Budkowska A, Khabiri AR. HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CFL responses. Biochem Biophys Res Commun 2007;354:641-649.
37. Romano M, Di NM, Pesce M. [HCV superinfection in a chronic carrier of HBV]. Minerva Gastroenterol Dietol 1995;41:303-305.
38. Yalcin K, Degertekin H, Yildiz F, Kilinc N. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin. J Gastroenterol 2003;38:796-800.
39. Sweet MJ, Hume DA. Endotoxin signal transduction in macrophages. J Leukoc Biol 1996;60:8-26.
40. Guidotti LG, McClary H, Loudis JM, Chisari FV. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med 2000;191:1247-1252.
41. Lopez-Guerrero JA, Carrasco L. Effect of nitric oxide on poliovirus infection of two human cell lines. J Virol 1998;72:2538-2540.
42. Keller F, Schmitt C, Kirn A. Interaction of mouse hepatitis virus 3 with Kupffer cells explanted from susceptible and resistant mouse strains. Antiviral activity, interleukin-1 synthesis. FEMS Microbiol Immunol 1988;1:87-95.